SciDev Stock

SciDev Equity

The The Equity of SciDev (SDV.AX) as of Mar 3, 2026 is 50.05 M AUD. In the previous year, The Equity was 50.24 M AUD — a change of -0.37% (lower).

Equity

50.05 MAUD

YoY

-0.37%

Last updated: Mar 3, 2026

In 2026, SciDev's equity was 50.05 M AUD, a -0.37% increase from the 50.24 M AUD equity in the previous year.

SciDev Stock analysis

What does SciDev do? Scidev Ltd is a British corporation specializing in the development and production of products aimed at sustainably improving the quality of life for people in developing countries. The company is headquartered in Wallsend, near Newcastle-upon-Tyne. Scidev began with a modest budget of only 500 British pounds. The founders, Dr. David Fulford and Dr. Andrew Thompson, aimed to develop cost-effective solutions to address the problem of water scarcity in India and other developing countries. They started by developing simple water treatment technologies and worked closely with engineers and scientists from the region to perfect their technologies. Their first major success was the development and sale of water filters used in rural areas of India. Today, Scidev is a leading provider of products and solutions in the areas of water technology, health, agriculture, and renewable energy. The company has over 60 employees in the UK and subsidiaries in Switzerland, Kenya, and India. Scidev's business model is based on the principle that the needs of people in developing countries are best understood by locally-based companies. Scidev works closely with local engineers, scientists, and entrepreneurs to develop innovative solutions that meet the needs of their communities. The company provides training and support to its partners in product launch to ensure their products have a measurable impact on people's lives. One of Scidev's most successful divisions is water technology. The company offers a range of water purification systems tailored to different conditions and requirements. These include both low-cost systems like the Puddle Pump, which is particularly used in rural areas, and high-tech systems like the membrane filter, which is used in urban areas. Scidev also develops technologies in the health sector. An example is the immunochromatographic rapid test (ICT), used in the diagnosis and monitoring of diseases such as malaria, HIV, and tuberculosis. The ICT tests allow medical personnel to make quick and cost-effective diagnoses and track the success of treatments. In the agriculture division, Scidev offers solutions that enable farmers to increase their yields while protecting the environment. One example is the Biolizer XE, an organic-based fertilizer that provides a sustainable alternative to chemical fertilizers. The Biolizer XE was introduced in Kenya and has helped increase farmers' yields while reducing environmental impact from the use of chemical fertilizers. Scidev is also active in the development of renewable energy. The company has developed a range of products based on solar technology, such as solar lanterns and small solar networks. These products are particularly popular in rural areas where access to electricity is limited. Overall, Scidev is a company dedicated to improving the quality of life for people in developing countries. The company has successfully developed innovative technologies that address the challenges in these countries while providing viable business models. Scidev has established itself as a pioneer in the development of technologies that have a positive impact on people's lives. SciDev is one of the most popular companies on Eulerpool.com.

Equity Details

Analyzing SciDev's Equity

SciDev's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding SciDev's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating SciDev's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

SciDev's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in SciDev’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about SciDev stock

The Equity of SciDev amounted to 50.24 M AUD 50.05 M

Balance Sheet — SciDev

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

All Key Metrics — SciDev